1. Home
  2. PASG vs BRNS Comparison

PASG vs BRNS Comparison

Compare PASG & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PASG
  • BRNS
  • Stock Information
  • Founded
  • PASG 2017
  • BRNS 2016
  • Country
  • PASG United States
  • BRNS United Kingdom
  • Employees
  • PASG N/A
  • BRNS N/A
  • Industry
  • PASG Biotechnology: Pharmaceutical Preparations
  • BRNS Biotechnology: Pharmaceutical Preparations
  • Sector
  • PASG Health Care
  • BRNS Health Care
  • Exchange
  • PASG Nasdaq
  • BRNS Nasdaq
  • Market Cap
  • PASG 42.2M
  • BRNS 41.0M
  • IPO Year
  • PASG 2020
  • BRNS 2021
  • Fundamental
  • Price
  • PASG $0.60
  • BRNS $1.04
  • Analyst Decision
  • PASG Strong Buy
  • BRNS Strong Buy
  • Analyst Count
  • PASG 3
  • BRNS 2
  • Target Price
  • PASG $8.00
  • BRNS $3.00
  • AVG Volume (30 Days)
  • PASG 886.7K
  • BRNS 46.0K
  • Earning Date
  • PASG 03-03-2025
  • BRNS 11-06-2024
  • Dividend Yield
  • PASG N/A
  • BRNS N/A
  • EPS Growth
  • PASG N/A
  • BRNS N/A
  • EPS
  • PASG N/A
  • BRNS N/A
  • Revenue
  • PASG N/A
  • BRNS $14,969,000.00
  • Revenue This Year
  • PASG N/A
  • BRNS $1,805.74
  • Revenue Next Year
  • PASG N/A
  • BRNS N/A
  • P/E Ratio
  • PASG N/A
  • BRNS N/A
  • Revenue Growth
  • PASG N/A
  • BRNS 106.21
  • 52 Week Low
  • PASG $0.45
  • BRNS $0.80
  • 52 Week High
  • PASG $1.79
  • BRNS $4.16
  • Technical
  • Relative Strength Index (RSI)
  • PASG 43.68
  • BRNS 48.42
  • Support Level
  • PASG $0.56
  • BRNS $0.91
  • Resistance Level
  • PASG $0.64
  • BRNS $1.15
  • Average True Range (ATR)
  • PASG 0.11
  • BRNS 0.15
  • MACD
  • PASG -0.01
  • BRNS -0.01
  • Stochastic Oscillator
  • PASG 8.69
  • BRNS 34.96

About PASG Passage Bio Inc.

Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.

About BRNS Barinthus Biotherapeutics plc

Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic that guide the immune system to overcome chronic infectious diseases, autoimmunity and cancer.

Share on Social Networks: